penicillamine has been researched along with Day Blindness in 8 studies
Penicillamine: 3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease.
penicillamine : An alpha-amino acid having the structure of valine substituted at the beta position with a sulfanyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Optic neuropathy developed in a patient with rheumatoid arthritis who had been receiving D-penicillamine for about 1 year." | 7.67 | Optic neuropathy associated with penicillamine therapy in a patient with rheumatoid arthritis. ( Burde, RM; Klingele, TG, 1984) |
| "Chloroquine and hydroxychloroquine effectively suppress rheumatoid arthritis with a superior benefit to risk ratio." | 5.05 | Antimalarial drugs for rheumatoid arthritis. ( Mackenzie, AH, 1983) |
| "Optic neuropathy developed in a patient with rheumatoid arthritis who had been receiving D-penicillamine for about 1 year." | 3.67 | Optic neuropathy associated with penicillamine therapy in a patient with rheumatoid arthritis. ( Burde, RM; Klingele, TG, 1984) |
| "A prospective controlled trial has recently been reported to show the effectiveness of D-penicillamine (DPA) in the prevention of retinopathy of prematurity (ROP) among infants less than 2000 g birth-weight." | 3.67 | One year longitudinal follow-up of premature infants treated with D-penicillamine in the neonatal period. ( Itzés, B; Lakatos, L; Oroszlán, G; Vekerdy-Lakatos, S, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (75.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goel, S | 1 |
| Sahay, P | 1 |
| Maharana, PK | 1 |
| Titiyal, JS | 1 |
| Abbaslou, P | 1 |
| Zaman, T | 1 |
| Klingele, TG | 1 |
| Burde, RM | 1 |
| Mackenzie, AH | 1 |
| Vekerdy-Lakatos, S | 1 |
| Lakatos, L | 1 |
| Oroszlán, G | 1 |
| Itzés, B | 1 |
| Rustam, H | 1 |
| Hamdi, T | 1 |
| van Oye, R | 1 |
| Tsubaki, T | 1 |
| Shirakawa, K | 1 |
| Kambayashi, K | 1 |
| Hirota, K | 1 |
1 trial available for penicillamine and Day Blindness
| Article | Year |
|---|---|
Antimalarial drugs for rheumatoid arthritis.
Topics: Amodiaquine; Antimalarials; Arthritis, Rheumatoid; Body Weight; Chloroquine; Clinical Trials as Topi | 1983 |
7 other studies available for penicillamine and Day Blindness
| Article | Year |
|---|---|
Ocular manifestations of Wilson's disease.
Topics: Adolescent; Anterior Eye Segment; Cataract; Chelating Agents; Descemet Membrane; Diet Therapy; Hepat | 2019 |
A Child with elemental mercury poisoning and unusual brain MRI findings.
Topics: Acrodynia; Antidotes; Brain; Chelating Agents; Child; Humans; Inhalation Exposure; Magnetic Resonanc | 2006 |
Optic neuropathy associated with penicillamine therapy in a patient with rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Fluorescein Angiography; Humans; Male; Middle Aged; Optic Nerve Diseases; Pap | 1984 |
One year longitudinal follow-up of premature infants treated with D-penicillamine in the neonatal period.
Topics: Child Development; Follow-Up Studies; Growth; Hospitalization; Humans; Infant Mortality; Infant, New | 1987 |
Methyl mercury poisoning in Iraq. A neurological study.
Topics: Adolescent; Adult; Ataxia; Cerebellar Diseases; Child; Child, Preschool; Decerebrate State; Disease | 1974 |
[Harmful effects of common drugs on the visual apparatus. The oligo-elements and chelating agents. B. Chelating agents].
Topics: Chelating Agents; Deferoxamine; Dimercaprol; Edetic Acid; Eye Diseases; Humans; Penicillamine; Visio | 1972 |
[Clinical features of organic mercury poisoning in the Agano River area].
Topics: Adult; Aged; Humans; Japan; Male; Mercury; Mercury Poisoning; Middle Aged; Paresthesia; Penicillamin | 1969 |